Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCL2 | P10415 | 10/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1810749 | 1.00 | BCL2 (1.00) | BCL2 | |
| SCHEMBL1957286 | 0.93 | BCL2 (0.92) | BCL2 | |
| SCHEMBL19424920 | 0.93 | BCL2 (0.86) | BCL2 | |
| SCHEMBL1959154 | 0.93 | BCL2 (1.00) | BCL2 | |
| SCHEMBL1955358 | 0.92 | BCL2 (0.86) | BCL2 | |
| SCHEMBL2505947 | 0.92 | BCL2 (0.85) | BCL2 | |
| SCHEMBL30313975 | 0.92 | BCL2 (1.00) | BCL2 | |
| SCHEMBL1810871 | 0.92 | BCL2 (1.00) | BCL2 | |
| SCHEMBL1957132 | 0.91 | BCL2 (0.84) | BCL2 | |
| SCHEMBL1958063 | 0.91 | BCL2 (0.97) | BCL2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4682148-A2 | APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES | AbbVie Ireland Unlimited Company (IE) | 2026-01-21 | — | — | EP | disclosed |
| EP-4474383-A2 | APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES | AbbVie Ireland Unlimited Company (IE) | 2024-12-11 | — | — | EP | disclosed |
| EP-4218731-A2 | MELT-EXTRUDED SOLID DISPERSIONS CONTAINING AN APOPTOSIS-INDUCING AGENT | AbbVie Ireland Unlimited Company (IE) | 2023-08-02 | — | — | EP | disclosed |